Evidence map›Paper›PMID 35311624›Full record

ArticleEpigenetics2022

DNA methylation profiles in pneumonia patients reflect changes in cell types and pneumonia severity.

Marco Morselli, Colin Farrell, Dennis Montoya, Tarık Gören, Ramazan Sabırlı, İbrahim Türkçüer, Özgür Kurt, Aylin Köseler, Matteo Pellegrini

Abstract read
In one paragraph

Article in Epigenetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marco MorselliDepartment of Molecular, Cell, and Developmental Biology, Institute for Genomics and Proteomics; University of California Los Angeles, Los Angeles, CA, USA.ORCID 0000-0003-3351-5791
Colin FarrellDepartment of Molecular, Cell, and Developmental Biology, University of California Los Angeles, Los Angeles, CA, USA.ORCID 0000-0002-3138-6108
Dennis MontoyaDepartment of Biochemistry and Molecular Medicine, University of California Davis Medical Center, Sacramento, CA, USA.ORCID 0000-0002-0802-3309
Tarık GörenDepartment of Emergency Medicine, Pamukkale University Faculty of Medicine, Denizli, Turkey.ORCID 0000-0002-8292-6717
Ramazan SabırlıDepartment of Emergency Medicine, Bakircay University School of Medicine, Cigli Training and Research Hospital, İzmir, Turkey.ORCID 0000-0003-4599-5833
İbrahim TürkçüerDepartment of Emergency Medicine, Pamukkale University Faculty of Medicine, Denizli, Turkey.ORCID 0000-0001-8342-4615
Özgür KurtDepartment of Medical Microbiology, Acibadem Mehmet Ali Aydinlar University School of Medicine, Istanbul, Turkey.ORCID 0000-0001-5575-588X
Aylin KöselerDepartment of Biophysics, Pamukkale University Faculty of Medicine, Denizli, Turkey.ORCID 0000-0003-4832-0436
Matteo PellegriniDepartment of Molecular, Cell, and Developmental Biology, Institute for Genomics and Proteomics; University of California Los Angeles, Los Angeles, CA, USA.ORCID 0000-0001-9355-9564

Funding

Validation and optimization of epigenetic clocksU01AG060908 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RITZ, BEATE R. · 2018 to 2022
$3.4M
Biomedical Big Data Training GrantT32CA201160 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PELLEGRINI, MATTEO · 2015 to 2015
$264k
NCI NIH HHS T32 CA201160NIA NIH HHS U01 AG060908
6 · The paper itself

Abstract

Immune cell-type composition changes with age, potentially weakening the response to infectious diseases. Profiling epigenetics marks of immune cells can help us understand the relationship with disease severity. We therefore leveraged a targeted DNA methylation method to study the differences in a cohort of pneumonia patients (both COVID-19 positive and negative) and unaffected individuals from peripheral blood.This approach allowed us to predict the pneumonia diagnosis with high accuracy (AUC = 0.92), and the PCR positivity to the SARS-CoV-2 viral genome with moderate, albeit lower, accuracy (AUC = 0.77). We were also able to predict the severity of pneumonia (PORT score) with an R

Indexed as

COVID-19PneumoniaBiomarkersDNA MethylationHumansSARS-CoV-2Biomarkersbiomarkerscell-type deconvolutionDNA methylationpneumoniaSARS-CoV-2targeted bisulfite sequencing

Identifiers

PMID35311624
PMCPMC9621067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.